拜卡林通过向SOCS1/NF-κB/STAT3轴来降低炎症以抑制肺癌
Lijuan Guo1, Ming Yue1, Chengyuan Ma1
1School of Pharmacy, Henan University, Kaifeng, 475004, China.
Heliyon
|April 17, 2024
概括
贝卡林是来自Scutellaria baicalensis的衍生物,通过减少炎症,有效地抑制肺癌的进展. 它针对SOCS1/NF-κB/STAT3通路,为肺癌提供了潜在的新治疗策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 炎症在肺癌的发展中起着至关重要的作用,影响扩散,转移,亡,血管生成和耐药性.
- 贝卡林是Scutellaria baicalensis的关键化合物,已在各种癌症类型中表现出抗癌性质,但其在肺癌中的特定作用和机制需要阐明.
研究的目的:
- 在体外 (A549细胞) 和体内 (尿诱导的小鼠模型) 两种情况下,研究baicalin的抗肺癌作用.
- 阐明贝卡林在肺癌中的作用背后的分子机制,重点关注其抗炎和抗癌特性.
主要方法:
- 实验室试验包括细胞活力,殖民地形成,伤口愈合,AO/EB染色和西部斑.
- 在体内研究中使用了尿诱导的小鼠肺癌模型,具有HE染色和IHC.
- 机制探索涉及网络药理学,分子对接,基因沉默和LPS诱导的炎症模型.
主要成果:
- 巴伊卡林在肺癌细胞中表现出显著的抗增殖,抗迁移,抗炎症和前性作用.
- 在体内,贝卡林有效抑制了尿诱导的小鼠肺癌的进展.
- 机械上,贝卡林上调了细胞因子信号传递1 (SOCS1) 的抑制剂,导致NF-κB/STAT3通路的失活.
结论:
- 拜卡林通过SOCS1/NF-κB/STAT3信号轴减轻炎症,显示出强大的抗肺癌活性.
- 向SOCS1代表了肺癌治疗的有前途的治疗策略.
- 巴伊卡林作为一种潜在的候选化合物,用于开发新型肺癌疗法.
相关概念视频
NF-κB-dependent Signaling Pathway
7.4K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K


